Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) Shares Outstanding (Diluted Average) (2021 - 2025)

Tenon Medical has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $7384.0 for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 508.24% year-over-year to $7384.0; the TTM value through Dec 2025 reached $7384.0, up 508.24%, while the annual FY2025 figure was $7384.0, 508.24% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $7384.0 at Tenon Medical, down from $8250.0 in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $8250.0 in Q3 2025 and troughed at $227.0 in Q4 2023.
  • A 5-year average of $2261.7 and a median of $990.0 in 2022 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 74.64% in 2023 and later skyrocketed 1518.55% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $903.0 in 2021, then fell by 11.3% to $801.0 in 2022, then tumbled by 71.66% to $227.0 in 2023, then soared by 434.8% to $1214.0 in 2024, then skyrocketed by 508.24% to $7384.0 in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for TNON at $7384.0 in Q4 2025, $8250.0 in Q3 2025, and $7591.0 in Q2 2025.